As U.S. Slashes $500M in mRNA Funding, Bordeaux Biotech bYoRNA Raises €1.5M to Reinvent RNA Production
bYoRNA is developing a patented fermentation process that could cut RNA production costs by 100x, improve safety, and enable global access to next-generation vaccines and therapies. This breakthrough comes as the U.S. is rejecting mRNA, a move that complicates the startup's business strategy.

Latest

From Rennes to Roblox: How Gaming Startup RIVRS is Betting Big On UGC Publishing Model In Asia
RIVRS is evolving from a French UGC game studio into a full-fledged publishing platform with a major Asia push. Launching a $1M Creator Fund and new hubs in Vietnam and Hong Kong, it’s betting on speed, AI, and partnerships to professionalize Roblox game creation.

La Machine #46: Special AI Cybersecurity Edition
It's Cybermois, France's cybersecurity month. For Part II of our special Cybersecurity package, we look at MokN's platform that uses AI and "fake doors" to trick hackers into revealing stolen credentials. CEOs Stu Solomon (HUMAN) and Philippe Humeau (CrowdSec) discuss the AI future of security.

How Cybersecurity Startup MokN Combats Phishing With Deceptive 'Fake Doors'
When stolen credentials breached his 'impenetrable' system, Gautier Bugeon had an insight: give attackers fake doors to try. His startup MokN raised €2.6M, hit $1M ARR in 16 months with half its clients being billion-dollar companies, and is now expanding to America.

When Bots Go Agentic: How AI Is Rewriting the Rules of Cybersecurity
The cyber arms race has accelerated: humans once led attacks, AI now augments them, and MOAIs may soon strike autonomously. The big question: can defenders evolve fast enough to match a threat that never sleeps and learns on the fly?